M&A Deal Summary

BC Platforms Acquires Medexprim

On December 7, 2023, BC Platforms acquired information technology company Medexprim

Acquisition Highlights
  • This is BC Platforms’ 1st transaction in the Information Technology sector.
  • This is BC Platforms’ 1st transaction in France.

M&A Deal Summary

Date 2023-12-07
Target Medexprim
Sector Information Technology
Buyer(s) BC Platforms
Deal Type Add-on Acquisition

Target

Medexprim

Labege, France
Medexprim is a real-world data company that builds bridges between European academic hospitals, and life sciences, AI, and medical device companies. The company provides its partners with regulatory-grade, multimodal, and multicentric datasets to help solve the “one patient, one disease, one treatment” equation, and accelerate personalized medicine. Medexprim is based in Labege, France.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

BC Platforms

Zurich, Switzerland

Category Company
Founded 1997
Sector Information Technology
DESCRIPTION

BC Platforms is a provider of powerful genomic data management and analysis solutions to address some of the biggest healthcare challenges today by leveraging the convergence of genomics and healthcare information technologies. BC Platforms was founded in 1997 and is based in Zurich, Switzerland.


DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: France M&A 1 of 1
Year: 2023 M&A 1 of 1